Stocktoria
INTEGRA LIFESCIENCES HOLDINGS CORP IART
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1995-08-16
INTEGRA LIFESCIENCES HOLDINGS CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.6B | $1.5B | $1.6B | $1.5B |
| SG&A expense | $699.7M | $717.0M | $656.6M | $616.3M | $637.4M |
| Operating income | -$493.4M | $28.4M | $111.5M | $238.9M | $197.2M |
| Interest expense | — | — | $51.4M | $49.6M | $50.4M |
| Income tax | -$47.0M | -$11.3M | $13.3M | $33.3M | $45.6M |
| Net income | -$516.5M | -$6.9M | $67.7M | $180.6M | $169.1M |
| EPS (diluted) | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 |
| Operating cash flow | $50.4M | $129.4M | $140.0M | $264.5M | $312.4M |
| Free cash flow | -$31.1M | $25.0M | $73.1M | $222.1M | $264.4M |
| Cash & equivalents | $235.0M | $246.4M | $276.4M | $456.7M | $513.4M |
| Inventory | $492.7M | $429.1M | $389.6M | $324.6M | $317.4M |
| Total assets | $3.6B | $4.0B | $3.8B | $3.9B | $3.8B |
| Total liabilities | $2.6B | $2.5B | $2.2B | $2.1B | $2.1B |
| Shareholders' equity | $1.0B | $1.5B | $1.6B | $1.8B | $1.7B |
Source: SEC EDGAR filings · CIK 0000917520 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.